Replies to post #123841 on Biotech Values

[exwannabe]

CLDX: As long as we are talking about Hammer's picks, what do you guys think of that CLDX?

2 mid stage drugs that could work, and their APC technology (using antibodies to deliver antigens to dendrite cells).

Seams like a reasonable shot at $120M.